| Using protein nanofibrils to remove azo dyes from aqueous solution by the coagulation process D Morshedi, Z Mohammadi, MMA Boojar, F Aliakbari Colloids and Surfaces B: Biointerfaces 112, 245-254, 2013 | 122 | 2013 |
| Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha‐Synuclein Fibrillation and Cytotoxicity D Morshedi, F Aliakbari, A Tayaranian‐Marvian, A Fassihi, F Pan‐Montojo, ... Journal of Food Science 80 (10), H2336-H2345, 2015 | 114 | 2015 |
| Curcumin-loaded amine-functionalized mesoporous silica nanoparticles inhibit α-synuclein fibrillation and reduce its cytotoxicity-associated effects N Taebnia, D Morshedi, S Yaghmaei, F Aliakbari, F Rahimi, A Arpanaei Langmuir 32 (50), 13394-13402, 2016 | 82 | 2016 |
| Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity H Mohammad-Beigi, F Aliakbari, C Sahin, C Lomax, A Tawfike, ... Journal of Biological Chemistry 294 (11), 4215-4232, 2019 | 76 | 2019 |
| Formulation and anti-neurotoxic activity of baicalein-incorporating neutral nanoliposome F Aliakbari, AA Shabani, H Bardania, H Mohammad-Beigi, AT Marvian, ... Colloids and Surfaces B: Biointerfaces 161, 578-587, 2018 | 45 | 2018 |
| Chitosan nanoparticles containing Physalis alkekengi-L extract: preparation, optimization and their antioxidant activity R Mahmoudi, M Tajali Ardakani, B Hajipour Verdom, A Bagheri, ... Bulletin of Materials Science 42, 1-6, 2019 | 42 | 2019 |
| The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease F Aliakbari, H Mohammad-Beigi, N Rezaei-Ghaleh, S Becker, ... Nanoscale 10 (19), 9174-9185, 2018 | 38 | 2018 |
| RGD-modified nano-liposomes encapsulated eptifibatide with proper hemocompatibility and cytotoxicity effect H Bardania, SA Shojaosadati, F Kobarfard, D Morshedi, F Aliakbari, ... Iranian Journal of Biotechnology 17 (2), e2008, 2019 | 35 | 2019 |
| In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies AT Marvian, DJ Koss, F Aliakbari, D Morshedi, TF Outeiro Journal of neurochemistry 150 (5), 535-565, 2019 | 31 | 2019 |
| The effect of mesoporous silica nanoparticle surface chemistry and concentration on the α-synuclein fibrillation N Taebnia, D Morshedi, M Doostkam, S Yaghmaei, F Aliakbari, G Singh, ... Rsc Advances 5 (75), 60966-60974, 2015 | 31 | 2015 |
| Temperature-dependent formulation of a hydrogel based on Hyaluronic acid-polydimethylsiloxane for biomedical applications M Khaleghi, E Ahmadi, MK Shahraki, F Aliakbari, D Morshedi Heliyon 6 (3), 2020 | 30 | 2020 |
| Gallic acid loaded onto polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA-GA NPs) stabilizes α-synuclein in the unfolded conformation and inhibits aggregation H Mohammad-Beigi, D Morshedi, SA Shojaosadati, JN Pedersen, ... Rsc Advances 6 (88), 85312-85323, 2016 | 28 | 2016 |
| New metal-organic framework coated sodium alginate for the delivery of curcumin as a sustainable drug delivery and cancer therapy system H Nabipour, F Aliakbari, K Volkening, MJ Strong, S Rohani International Journal of Biological Macromolecules 259, 128875, 2024 | 26 | 2024 |
| Theranostic magnetite cluster@ silica@ albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents SA Maboudi, SA Shojaosadati, F Aliakbari, A Arpanaei Materials Science and Engineering: C 99, 1485-1492, 2019 | 25 | 2019 |
| Natural occurrence of Fusarium species in maize kernels at Gholestan province in Northern Iran. F Aliakbari, M Mirabolfathy, M Emami, SF Mazhar, R Karami-Osboo | 23 | 2007 |
| The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells H Hourfar, F Aliakbari, SR Aqdam, Z Nayeri, H Bardania, DE Otzen, ... International Journal of Biological Macromolecules 229, 305-320, 2023 | 21 | 2023 |
| Identification and characterization of a compound from Cuminum cyminum essential oil with antifibrilation and cytotoxic effect D Morshedi, TS Kesejini, F Aliakbari, R Karami-Osboo, M Shakibaei, ... Research in pharmaceutical sciences 9 (6), 431-443, 2014 | 21 | 2014 |
| Formulation of nanoliposome-encapsulated bevacizumab (Avastin): Statistical optimization for enhanced drug encapsulation and properties evaluation M Malakouti-Nejad, H Bardania, F Aliakbari, A Baradaran-Rafii, E Elahi, ... International journal of pharmaceutics 590, 119895, 2020 | 20 | 2020 |
| Multiple Protective Roles of Nanoliposome‐Incorporated Baicalein against Alpha‐Synuclein Aggregates F Aliakbari, H Mohammad‐Beigi, S Abbasi, N Rezaei‐Ghaleh, F Lermyte, ... Advanced Functional Materials 31 (7), 2007765, 2021 | 19 | 2021 |
| The primary neuronal cells are more resistant than PC12 cells to α-synuclein toxic aggregates M Heravi, L Dargahi, S Parsafar, AT Marvian, F Aliakbari, D Morshedi Neuroscience letters 701, 38-47, 2019 | 17 | 2019 |
Dina MorshediAssociate professor biochemistry, National Institute of genetic engineering and biotechnologyVerified email at nigeb.ac.ir
